Profarma Distribuidora de Produtos Farmacêuticos S.A. (PFRM3.SA)
BRL 6.2
(1.47%)
BRL 6.2
(1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.66 Billion | 7.81 Billion | 6.41 Billion | 5.48 Billion | 4.8 Billion | 4.27 Billion |
| Cost of Revenue | 7.36 Billion | 6.67 Billion | 5.5 Billion | 4.71 Billion | 4.06 Billion | 3.59 Billion |
| Gross Profit | 1.29 Billion | 1.14 Billion | 907.57 Million | 763.56 Million | 737.83 Million | 680.91 Million |
| Operating Expenses | 1.04 Billion | 902.56 Million | 782.83 Million | 647.02 Million | 679.47 Million | 628.08 Million |
| Selling, General and Administrative Expenses | 1.04 Billion | 112 Million | 491.66 Million | 415.11 Million | 420.48 Million | 479.01 Million |
| Research and Development Expenses | - | - | - | - | - | 61 Thousand |
| Other Expenses | - | 790.55 Million | 291.17 Million | 231.91 Million | 258.99 Million | 22.5 Million |
| Cost and Expenses | 8.41 Billion | 7.57 Billion | 6.28 Billion | 5.36 Billion | 4.74 Billion | 4.21 Billion |
| Operating Income | 245.61 Million | 227.88 Million | 122.15 Million | 99.84 Million | 147.08 Million | -625.99 Million |
| Interest Expense | 168.31 Million | 149.19 Million | 76.15 Million | 67.21 Million | 93.12 Million | 66.65 Million |
| Income Tax Expense | 3.73 Million | -6.07 Million | -30.36 Million | -28.64 Million | 9.57 Million | -20.39 Million |
| Earnings before Tax | 81.59 Million | 78.97 Million | 48.74 Million | 33.14 Million | 21.55 Million | -30.13 Million |
| Net Income | 70.39 Million | 80.87 Million | 78.19 Million | 52.33 Million | 11.97 Million | -9.73 Million |
| Earnings Per Share Basic | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | -0.08 |
| Earnings Per Share Diluted | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | -0.08 |
| Weighted Average Shares Outstanding | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 117.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 117.14 Million |
| Gross Margin | 0.15 | 0.15 | 0.14 | 0.14 | 0.15 | 0.16 |
| EBIT Margin | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.02 |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | -0.00 |
| EBITDA | 398.41 Million | 380.43 Million | 226.44 Million | 199.27 Million | 206.75 Million | 75.74 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | -0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.6 Billion | 2.28 Billion | 2.25 Billion | 8.66 Billion | 2.2 Billion | 2.29 Billion |
| Cost of Revenue | 2.2 Billion | 1.89 Billion | 1.92 Billion | 7.36 Billion | 1.76 Billion | 1.95 Billion |
| Gross Profit | 395.64 Million | 386.49 Million | 327.02 Million | 1.29 Billion | 439.53 Million | 337.78 Million |
| Operating Expenses | 309.48 Million | 299.2 Million | 285.25 Million | 1.04 Billion | 377.71 Million | 265.15 Million |
| Selling, General and Administrative Expenses | 309.48 Million | 299.2 Million | 285.25 Million | - | 377.71 Million | 29.11 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 311.83 Million | - | - | - | - |
| Cost and Expenses | 2.51 Billion | 2.19 Billion | 2.2 Billion | 8.41 Billion | 2.14 Billion | 2.22 Billion |
| Operating Income | 86.16 Million | 87.28 Million | 41.77 Million | 245.61 Million | 61.81 Million | 70.12 Million |
| Interest Expense | 38.43 Million | 27.42 Million | 27.9 Million | 168.31 Million | 38.45 Million | 33.95 Million |
| Income Tax Expense | 3.47 Million | 13.35 Million | -2.37 Million | 3.73 Million | 229 Thousand | 1.95 Million |
| Earnings before Tax | 55.77 Million | 45.19 Million | -327 Thousand | 81.58 Million | 31.71 Million | 36.17 Million |
| Net Income | 49.02 Million | 28.3 Million | 1.7 Million | 70.39 Million | 28.41 Million | 32.16 Million |
| Earnings Per Share Basic | 0.40 | 0.23 | 0.01 | - | 0.23 | 0.26 |
| Earnings Per Share Diluted | 0.40 | 0.23 | 0.01 | - | 0.23 | 0.26 |
| Weighted Average Shares Outstanding | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million | 122.61 Million |
| Gross Margin | 0.15 | 0.17 | 0.15 | 0.15 | 0.20 | 0.15 |
| EBIT Margin | 0.05 | 0.06 | 0.04 | - | 0.05 | 0.05 |
| Profit Margin | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| EBITDA | 136.98 Million | 128.52 Million | 81.77 Million | - | 100.49 Million | 107.92 Million |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 |
GUID
8207
002747
AIIXY
1967
600610